Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
The quest for innovative drug delivery systems has taken a fascinating turn with recent research inspired by cephalopods. Scientists from the Massachusetts Institute of Technology (MIT) and Novo Nordisk have spearheaded the study, delving into a needle-free drug delivery system modeled after the
November 20, 2024The healthcare landscape is on the brink of a profound transformation, driven by rapid technological advancements, evolving societal needs, and shifting demographic patterns. By 2025, innovations in AI, remote medicine, and biotechnology are expected to revolutionize healthcare delivery, making it
November 20, 2024The recent hospital safety ratings in Florida have sparked significant discussion, especially with Tampa General Hospital receiving a C grade from Leapfrog, an independent nonprofit that rates hospital safety. This rating marks the fifth time in the last six Leapfrog assessments that the hospital
November 19, 2024Johnson & Johnson (J&J) has announced promising topline results from its Phase III ICONIC-LEAD trial evaluating icotrokinra (JNJ-2113) for the treatment of moderate to severe plaque psoriasis in patients aged 12 and older. The study revealed that 64.7% of participants treated with
November 19, 2024The COVID-19 pandemic has brought unprecedented challenges to global health, but recent research suggests it may also offer unexpected benefits. Scientists from the Northwestern Medicine Canning Thoracic Institute have discovered a surprising link between the immune response to COVID-19 and cancer
November 19, 2024Doctors have embarked on a groundbreaking study to understand why a unique group of cancer patients, known as "super-survivors," manage to live far longer than expected after being diagnosed with particularly aggressive cancers. This major investigation involves not only eight NHS cancer
November 19, 2024With President-elect Donald J. Trump officially moving into the White House, manufacturing business leaders have quickly laid out their top priorities for his administration, eager to see substantial changes that will benefit their industry. Among the most prominent of these priorities is the
November 19, 2024In a groundbreaking study led by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt, the association between infant antibiotic use and the subsequent development of childhood asthma is being meticulously explored. This research, spearheaded by Dr. Christian Rosas-Salazar, seeks
November 19, 2024Patients with type 2 diabetes often confront a myriad of challenges, one of which is the detrimental impact on kidney function. Recent research has been focusing on how SGLT2 inhibitors, particularly canagliflozin, might offer a solution to these problems by improving kidney health and oxygenation.
November 18, 2024The development of synthetic intramembrane proteolysis receptors (SNIPRs) engineered by researchers in the United States could be a game-changer for CAR T-cell cancer therapies. This groundbreaking advancement introduces a novel methodology to enhance the precision and safety of CAR T-cell
November 18, 2024ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy